CO-EVOLVED LEADS Trademark

Trademark Overview

On Tuesday, December 8, 2020, a trademark application was filed for CO-EVOLVED LEADS with the United States Patent and Trademark Office. The USPTO has given the CO-EVOLVED LEADS trademark a serial number of 90365978. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Thursday, July 18, 2024. This trademark is owned by Empress Therapeutics, Inc.. The CO-EVOLVED LEADS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and therapeutic pharmaceuticals, both for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders
co-evolved leads

General Information

Serial Number90365978
Word MarkCO-EVOLVED LEADS
Filing DateTuesday, December 8, 2020
Status734 - FIFTH EXTENSION - GRANTED
Status DateThursday, July 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 23, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations and therapeutic pharmaceuticals, both for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 12, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEmpress Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameEmpress Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Friday, December 11, 2020NEW APPLICATION ENTERED
Friday, February 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 27, 2021ASSIGNED TO EXAMINER
Thursday, October 7, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 2, 2021NON-FINAL ACTION E-MAILED
Wednesday, June 2, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 2, 2021NON-FINAL ACTION WRITTEN
Thursday, October 7, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 7, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 20, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 3, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 23, 2021PUBLISHED FOR OPPOSITION
Tuesday, November 23, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, July 13, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, July 13, 2022SOU EXTENSION 1 FILED
Wednesday, July 13, 2022SOU EXTENSION 1 GRANTED
Tuesday, January 18, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, January 12, 2023SOU EXTENSION 2 GRANTED
Friday, July 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 12, 2023SOU TEAS EXTENSION RECEIVED
Thursday, January 12, 2023SOU EXTENSION 2 FILED
Saturday, January 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 13, 2023SOU TEAS EXTENSION RECEIVED
Thursday, July 13, 2023SOU EXTENSION 3 FILED
Thursday, July 13, 2023SOU EXTENSION 3 GRANTED
Friday, January 12, 2024SOU TEAS EXTENSION RECEIVED
Friday, January 12, 2024SOU EXTENSION 4 FILED
Friday, January 12, 2024SOU EXTENSION 4 GRANTED
Tuesday, January 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, July 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 18, 2024SOU EXTENSION 5 FILED
Thursday, July 18, 2024SOU EXTENSION 5 GRANTED
Wednesday, July 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 18, 2024SOU TEAS EXTENSION RECEIVED

Related Keywords

leads evolved disorders diseases related endocrinological metabolic neurodegenerative neurological system immune therapeutic